Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Rang in Aktien #29818
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Aktienkurs
$7.00
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$19.47M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-35.19%
Land
CA
Handel Devonian Health Group Inc. (DVHGF)

Kategorie

Aktien-Split-Historie für Devonian Health Group Inc. (DVHGF)
Die Aktie Devonian Health Group Inc. (Symbol: DVHGF) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 19, 2026 statt.
Eine DVHGF-Aktie, die vor dem Aug 19, 2026 gekauft wurde, entspricht heute 0 DVHGF-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR